|
🐢
|
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
17 auth.
L. Looijenga,
H. Stoop,
H. de Leeuw,
C. A. de Gouveia Brazao,
A. Gillis,
K. V. van Roozendaal,
E. J. V. van Zoelen,
R. Weber,
K. Wolffenbuttel,
H. van Dekken,
...
F. Honecker,
C. Bokemeyer,
E. Perlman,
D. Schneider,
J. Kononen,
G. Sauter,
J. Oosterhuis
|
9 |
2003 |
9
🐢
|
|
🐜
|
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
10 auth.
M. Glabbeke,
A. Oosterom,
J. Oosterhuis,
H. Mouridsen,
D. Crowther,
R. Somers,
...
J. Verweij,
A. Santoro,
J. Buesa,
T. Tursz
|
8 |
1999 |
8
🐜
|
|
🐜
|
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
12 auth.
E. Gortzak,
A. Azzarelli,
J. Buesa,
V. Bramwell,
F. Coevorden,
A. N. Geel,
...
A. Ezzat,
A. Santoro,
J. Oosterhuis,
M. Glabbeke,
A. Kirkpatrick,
J. Verweij
|
8 |
2001 |
8
🐜
|
|
🐜
|
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis.
15 auth.
N. Verstegen,
J. Oosterhuis,
D. Palma,
G. Rodrigues,
F. Lagerwaard,
A. V. D. Elst,
R. Mollema,
W. F. Tets,
A. Warner,
J. Joosten,
...
M. Amir,
C. Haasbeek,
E. Smit,
B. Slotman,
S. Senan
|
8 |
2013 |
8
🐜
|
|
🐜
|
The Y deletion gr/gr and susceptibility to testicular germ cell tumor.
49 auth.
K. Nathanson,
P. Kanetsky,
R. Hawes,
D. Vaughn,
R. Letrero,
K. Tucker,
M. Friedlander,
K. Phillips,
D. Hogg,
M. Jewett,
Radka Lohynska,
G. Daugaard,
S. Richard,
A. Chompret,
C. Bonaïti‐pellié,
...
A. Heidenreich,
E. Oláh,
L. Géczi,
I. Bodrogi,
W. Ormiston,
P. Daly,
J. Oosterhuis,
A. Gillis,
Leendert H. J. Looijenga,
P. Guilford,
S. Fosså,
K. Heimdal,
S. Tjulandin,
L. Liubchenko,
H. Stoll,
W. Weber,
M. Rudd,
R. Huddart,
G. Crockford,
D. Forman,
D. T. Oliver,
L. Einhorn,
B. Weber,
J. Kramer,
M. McMaster,
Mark H. Greene,
M. Pike,
V. Cortessis,
Chu Chen,
S. Schwartz,
D. Bishop,
D. Easton,
Michael R. Stratton,
E. Rapley
|
7 |
2005 |
7
🐜
|
|
🐢
|
Minimally invasive autopsy: an alternative to conventional autopsy?
A. Weustink,
M. M. Hunink,
C. V. van Dijke,
N. S. Renken,
G. Krestin,
J. Oosterhuis
|
7 |
2009 |
7
🐢
|
|
🦁
|
Human germ cell tumours from a developmental perspective
J. Oosterhuis,
Leendert H. J. Looijenga
|
7 |
2019 |
7
🦁
|
|
🐢
|
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
17 auth.
L. Looijenga,
H. de Leeuw,
Monique van Oorschot,
R. van Gurp,
H. Stoop,
A. Gillis,
C. A. de Gouveia Brazao,
R. Weber,
W. Kirkels,
T. V. van Dijk,
...
M. von Lindern,
P. Valk,
Geczy Lajos,
E. Oláh,
J. Nesland,
S. Fosså,
J. Oosterhuis
|
7 |
2003 |
7
🐢
|
|
🐜
|
Tumor Risk in Disorders of Sex Development
10 auth.
J. Pleskacova,
R. Hersmus,
J. Oosterhuis,
B. Setyawati,
S. Faradz,
M. Cools,
...
K. Wolffenbuttel,
J. Lebl,
S. Drop,
L. Looijenga
|
7 |
2010 |
7
🐜
|
|
🐜
|
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.
14 auth.
A. McIntyre,
B. Summersgill,
B. Grygalewicz,
A. Gillis,
J. Stoop,
Ruud J. H. L. M. van Gurp,
N. Dennis,
C. Fisher,
R. Huddart,
C. Cooper,
...
Jeremy Clark,
J. Oosterhuis,
Leendert H. J. Looijenga,
J. Shipley
|
7 |
2005 |
7
🐜
|
|
🐜
|
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
14 auth.
O. S. Nielsen,
I. Judson,
Q. V. Hoesel,
A. Cesne,
H. Keizer,
J. Blay,
A. Oosterom,
J. Radford,
L. Svancárová,
K. Krzemienlecki,
...
C. Hermans,
M. Glabbeke,
J. Oosterhuis,
J. Verweij
|
7 |
2000 |
7
🐜
|
